AZTA
Azenta, Inc. · NASDAQ
- Sector Health Services
- Industry Medical/Nursing Services
- Website azenta.com
- Employees(FY) 3500
- ISIN US1143401024
Performance
-3.23%
1W
-1.25%
1M
-3.53%
3M
-13.29%
6M
-30.01%
YTD
-20.92%
1Y
Profile
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Technical Analysis of AZTA 2024-12-06
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-03 19:00
AZTA: Raising target price to $38.00(Argus Research)
- 2024-11-29 01:00
- 2024-11-26 19:00
AZTA: Raising target price to $37.00(Argus Research)
- 2024-11-20 06:11
Daily – Vickers Top Buyers & Sellers for 11/20/2024(Argus Research)
- 2024-11-19 17:56
- 2024-11-19 04:56
- 2024-11-17 08:58
- 2024-11-16 07:45
- 2024-11-14 08:00
- 2024-11-14 05:59
Calculating The Intrinsic Value Of Azenta, Inc. (NASDAQ:AZTA)(Simply Wall St.)
- 2024-11-14 05:47
Azenta Full Year 2024 Earnings: EPS Misses Expectations(Simply Wall St.)
- 2024-11-13 19:00
- 2024-11-13 02:17
- 2024-11-12 19:00
AZTA: What does Argus have to say about AZTA?(Argus Research)
- 2024-11-12 16:05
- 2024-11-12 03:05
- 2024-11-05 19:00
AZTA: Raising target price to $37.00(Argus Research)
- 2024-11-04 16:05
- 2024-11-04 08:00
- 2024-11-04 03:05
- 2024-11-03 19:00
- 2024-10-30 16:05
- 2024-10-30 04:05
- 2024-10-08 20:00
AZTA: Lowering target price to $37.00(Argus Research)
- 2024-09-04 08:00
- 2024-09-03 20:00
- 2024-08-27 20:00
AZTA: Lowering target price to $39.00(Argus Research)
- 2024-08-20 20:00
AZTA: What does Argus have to say about AZTA?(Argus Research)
- 2024-08-12 16:05
- 2024-08-12 08:44
Page 1 of 6
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.